The FDA wants to place warning labels on food packages to combat obesity and other health conditions
The Food and Drug Administration (FDA) is looking to propose the inclusion of front-of-package warning labels that detail the ...
FDA to propose new food label warnings to combat obesity
The FDA is considering food labels to help consumers identify products with unhealthy ingredients, but some experts wonder if ...
STAT13h
FDA cites Granules, a large Indian generic drug manufacturer, for tossing truckloads of key documents
FDA cites Granules, a large Indian generic drug manufacturer, for tossing truckloads of important documents from a facility ...
USA Today15d
FDA approved new COVID-19 vaccines. Here's what to know and where to get them
The U.S. Food and Drug Administration recently green-lit new 2024-25 COVID-19 vaccinations ahead of the fall and winter ...
Food Safety News4d
FDA warns food companies for violations in acidified foods and seafood imports
The Food and Drug Administration sends warning letters to entities under its jurisdiction as part of its enforcement ...
Neu-REFIX Beta glucan receives rare pediatric disease and orphan drug designations from the US FDA for treatment of Duchenne Muscular Dystrophy
Neu refix granted orphan disease designation (ODD) & rare pediatric disease designation (RPDD) by US FDA for treatment of ...
USA Today4d
New eczema drug from Eli Lilly receives FDA approval for children and adults
On Friday, the U.S. Food and Drug Administration approved Eli Lilly's eczema drug for use in adults and children 12 ...
US allows increased production of Takeda's ADHD drug and its generics to address shortage
The production limit for lisdexamfetamine was increased by 6,236 kilograms, which includes 1,558 kg to address increased ...
JD Supra4d
Recap of the FDA and CTTI Public Workshop on AI in Drug Development
On August 6, 2024, the Food and Drug Administration (FDA) partnered with the Clinical Trials Transformation Initiative ...
Kisqali wins FDA nod for breast cancer treatment: Dosage, effectiveness and side effects of the breakthrough drug
The US FDA has approved Kisqali (ribociclib) for treating early-stage breast cancer in combination with hormone therapy. It ...